Goldman Sachs
AEON.WS

Goldman Sachs’s AEON Biopharma Inc AEON.WS Stock Holding History

Goldman Sachs’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-79,526
Closed -$115K – 6046
2024
Q1 		$115K Hold
79,526
– – ﹤0.01% 5225
2023
Q4 		$5.96K Hold
79,526
– – ﹤0.01% 5516
2023
Q3 		$11.9K Hold
79,526
– – ﹤0.01% 5395
2023
Q2 		$7.16K Hold
79,526
– – ﹤0.01% 5611
2023
Q1 		$4.37K Hold
79,526
– – ﹤0.01% 5806
2022
Q4 		$3.63K Hold
79,526
– – ﹤0.01% 5834
2022
Q3 		$4K Buy
79,526
+142
+0.2% +$13 ﹤0.01% 6112
2022
Q2 		$12K Hold
79,384
– – ﹤0.01% 6245
2022
Q1 		$22K Hold
79,384
– – ﹤0.01% 6396
2021
Q4 		$40K Hold
79,384
– – ﹤0.01% 6302
2021
Q3 		$46K Hold
79,384
– – ﹤0.01% 6062
2021
Q2 		$79K Buy
+79,384
New +$60.3K ﹤0.01% 5999

Goldman Sachs's AEON.WS Position: Q2 2024 in Review

Goldman Sachs sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 79,526 shares — an estimated $115K sold.

Goldman Sachs first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $115K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

  • Goldman Sachs reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 79,526 AEON Biopharma Inc shares in Q2 2024, an estimated $115K.
  • Goldman Sachs first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
  • Goldman Sachs's AEON Biopharma Inc position peaked at $115K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.